Neurogene Inc (NGNE)
36.42
+1.60
(+4.60%)
USD |
NASDAQ |
Jun 28, 16:00
36.40
-0.02
(-0.05%)
After-Hours: 20:00
Neurogene 1 Year Total Returns (Daily): 124.8% for June 28, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 28, 2024 | 124.8% |
| June 27, 2024 | 115.4% |
| June 26, 2024 | 103.9% |
| June 25, 2024 | 101.7% |
| June 24, 2024 | 105.9% |
| June 21, 2024 | 99.88% |
| June 20, 2024 | 97.62% |
| June 18, 2024 | 95.82% |
| June 17, 2024 | 158.3% |
| June 14, 2024 | 183.9% |
| June 13, 2024 | 172.7% |
| June 12, 2024 | 138.3% |
| June 11, 2024 | 138.3% |
| June 10, 2024 | 139.4% |
| June 07, 2024 | 137.6% |
| June 06, 2024 | 129.7% |
| June 05, 2024 | 131.6% |
| June 04, 2024 | 130.1% |
| June 03, 2024 | 127.0% |
| May 31, 2024 | 135.0% |
| May 30, 2024 | 108.8% |
| May 29, 2024 | 103.3% |
| May 28, 2024 | 93.35% |
| May 24, 2024 | 85.54% |
| May 23, 2024 | 78.92% |
| Date | Value |
|---|---|
| May 22, 2024 | 80.20% |
| May 21, 2024 | 86.92% |
| May 20, 2024 | 95.48% |
| May 17, 2024 | 91.46% |
| May 16, 2024 | 91.59% |
| May 15, 2024 | 94.16% |
| May 14, 2024 | 79.26% |
| May 13, 2024 | 74.09% |
| May 10, 2024 | 81.44% |
| May 09, 2024 | 86.59% |
| May 08, 2024 | 86.93% |
| May 07, 2024 | 88.77% |
| May 06, 2024 | 82.48% |
| May 03, 2024 | 108.1% |
| May 02, 2024 | 94.47% |
| May 01, 2024 | 87.61% |
| April 30, 2024 | 92.75% |
| April 29, 2024 | 86.72% |
| April 26, 2024 | 76.36% |
| April 25, 2024 | 76.77% |
| April 24, 2024 | 84.33% |
| April 23, 2024 | 83.35% |
| April 22, 2024 | 80.06% |
| April 19, 2024 | 88.12% |
| April 18, 2024 | 97.40% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.37%
Minimum
Nov 16 2022
630.2%
Maximum
Jun 19 2020
58.31%
Average
-7.08%
Median
1 Year Total Returns (Daily) Benchmarks
| Taysha Gene Therapies Inc | 276.3% |
| CEL-SCI Corp | -49.12% |
| AIM ImmunoTech Inc | -36.83% |
| IGC Pharma Inc | 41.26% |
| NovaBay Pharmaceuticals Inc | -91.58% |